Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

The #ALS space—and the HEALEY ALS Platform Trial—saw two more failures this week, from Denali Therapeutics and AbbVie/Calico Life Sciences. After a disappointing 2024 for the space ...

Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...

The multi-centre, placebo-controlled, double-blind trial will assess the therapy’s safety, pharmacodynamics, efficacy, and pharmacokinetics in adult ALS patients. Sean M Healey & AMG Centre for ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Chelsee Healey has exited 'Dancing on Ice'. The 36-year-old actress has left the ITV show after she was revealed to be the celebrity with the fewest public votes. Chelsee was visibly upset by her ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

The turn of events spelt the end for one notable competitor as Chelsee Healey found herself leaving the series. Upon her exit, Chelsee commented while holding back tears: "It's fine." Holly ...

Chelsee Healy sparked concern from Dancing on Ice fans on Sunday, with the star looking out of sorts as she revealed she'd been 'struggling' behind the scenes, seconds after she was eliminated ...